Medical marijuana is gaining widespread acceptance due to increased awareness. Notably, many nations are looking into cannabis instead of present drugs. So, Tilray expects about 40–80 nations to legalize medical cannabis over the next two or three years. To study more, read Tilray’s Stock Price Is Subdued Regardless of Global Opportunities.
Presently, there are studies associated with medical cannabis to treat:
- nausea and vomiting—effects of chemotherapy in cancer sufferers
- chronic pain related to traumatic spinal cord injuries, spina bifida, and osteoarthritis
- decreasing muscle stiffness
- a number of scleroses
- psychological disorders
- Crohn’s illness and quite a lot of illnesses
Overall, there’s a widespread belief within the healthcare community that medical marijuana helps alleviate the above situations. Notably, firms like Tilray and Canopy Growth already sell medical cannabis. They’re conducting clinical trials on the effectiveness of utilizing cannabis for medical treatment.
While there’s a whole lot of optimism about cannabis use, there’s another side to the story. There’s a scarcity of research on the effectiveness of medical cannabis. Because of this, there are concerns about utilizing cannabis as a substitute for traditional medication. A study discovered a modest link between cannabis use and a rise in systolic blood pressure in US adults. Overall, the study concluded that “With the legalization of cannabis, they’re a necessity for pre-clinical, clinical and prospective inhabitants-based analysis on the cardiovascular effects of cannabis use.”